Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Ruxolitinib | 0.3 | uM | 3 | IL18 | 18.0 | 61 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 3 | IL18 | 16.0 | 79 | ||||
RA2159 | IKK16 | 2.0 | uM | 3 | IL18 | 19.0 | 55 | ||||
RA2159 | JNK-IN-8 | 3.0 | uM | 3 | IL18 | 17.5 | 88 | ||||
N2586 | 3 | IL18 | 68.0 | 74 | |||||||
N2586 | PD184352 | 0.1 | uM | 3 | IL18 | 76.5 | 76 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 3 | IL18 | 49.0 | 74 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 3 | IL18 | 98.5 | 76 | ||||
N2586 | Tofacitinib | 0.3 | uM | 3 | IL18 | 55.0 | 72 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | IL18 | 49.0 | 53 | ||||
N2586 | JNK-IN-8 | 3.0 | uM | 3 | IL18 | 52.0 | 64 | ||||
RA2159 | IL-17A | 100 | ng/mL | 3 | IL18 | 19.0 | 75 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 3 | IL18 | 20.5 | 78 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | IL18 | 17.0 | 77 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | IL18 | 21.5 | 68 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | IL18 | 18.0 | 87 | |
RA2159 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 3 | IL18 | 20.0 | 83 | |
N2586 | IL-17A | 100 | ng/mL | 3 | IL18 | 70.0 | 72 | ||||
N2586 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 3 | IL18 | 72.0 | 75 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | IL18 | 50.0 | 58 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | IL18 | 123.0 | 69 | |
N2586 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | IL18 | 48.5 | 70 | |
N2586 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 3 | IL18 | 46.0 | 68 | |
RA2159 | IL-6 | 100 | ug/mL | 3 | IL18 | 19.0 | 80 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 3 | IL18 | 18.0 | 71 |